Skip to main content

Table 2 Treatment substances administered to horses of the three treatment groups on days 1, 22 and 78

From: Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma

Vaccine component Dose per injection
  Group eqIL12/18 Group hgp100 Group htyr
MIDGE-Th1 eqIL12 200 μg 200 μg 200 μg
MIDGE-Th1 eqILRAPIL18 200 μg 200 μg 200 μg
MIDGE-Th1 hgp100 - 500 μg -
MIDGE-Th1 htyr - - 500 μg
SAINT 18 0.35 μmol 0.675 μmol 0.675 μmol